Immuno-Oncology | Specialty

Role of PRRT in the Management of NETs

March 1st 2018

Deciding on SSA Treatment in NETs

March 1st 2018

Overview of Somatostatin Analogs for NETs

March 1st 2018

Symptom Control in Functional NETs

March 1st 2018

Risk Stratification and Management of NETs

March 1st 2018

Surgical Considerations for Neuroendocrine Tumors

March 1st 2018

Advances in the Management of NETs

March 1st 2018

Future Outlook in Pancreatic Cancer

February 27th 2018

Promising New Therapies in Pancreatic Cancer

February 27th 2018

Pancreatic Cancer: Looking Beyond Second-Line Therapy

February 27th 2018

Immunotherapy in MSI-High Pancreatic Tumors

February 27th 2018

Second-Line Decision-Making in Pancreatic Cancer

February 27th 2018

Impact of Second-Line Approval of Liposomal Irinotecan

February 27th 2018

Pancreatic Cancer: Data With Liposomal Irinotecan/5-FU

February 27th 2018

Dosing Options With Nab-Paclitaxel/Gemcitabine

February 27th 2018

Sequencing Strategies in Pancreatic Cancer

February 27th 2018

Choosing Frontline Therapy in Metastatic Disease

February 27th 2018

Recent Advances in Pancreatic Cancer Research

February 27th 2018

Hepatocellular Carcinoma: Future Role of Immunotherapy

February 27th 2018

Optimizing Checkpoint Inhibitor Combinations in HCC

February 27th 2018

x